Abstract:Background and Purpose:Rectal cancer is a common malignancy in China.Surgery is the first option for the treatment.Adjuvant radiotherapy can improve local control after surgery for stage Ⅱ/Ⅲ patients.However,whether escalation of radiation dose can further improve the local control and even the survival are unknown.This study analyzed the efficacy of adjuvant radiotherapy and its dose-response relationship.Methods:Seventy-four patients with stage Ⅱ and stage Ⅲ rectal cancer who received postoperative adjuvant radiotherapy were retrospectively analyzed.All the patients received conventional irradiation with 1.8-2.0Gy per fraction daily.The total dose was 40-70Gy(median:54Gy).Sixty-two patients received 1-10 cycles of sequential or concurrent 5-FU based chemotherapy.SPSS 11.5 is used for statistics,the survival rate is calculated by the actuarial method of Kaplan and Meier.Results:The median follow-up was 44.6months(ranges 7.3-119.9 mo).The 5-year overall survival rate and disease-free survival rate are 58% and 60% respectively.Fourteen patients had local recurrence,and 17 patients experienced distant metastasis.All patients were subdivided into three dose groups with the dosage of ≤50 Gy,50-60 Gy and >60 Gy.The 5-year local control rates are 92%,71% and 87% respectively(P=0.9194),and 5-year overall survival rate are 68%,62% and 53% respectively(P=0.4194).There is no significant difference of overall survival and local control rate between these three dose groups.Five patients with dose of more than 50Gy died of late toxicities.Conclusions:Adjuvant radiotherapy for Stage Ⅱ and Ⅲ patients with rectal cancer dose not show dose response.There is no improvement of local control and survival due to the escalation of dose.The dose of conventional radiotherapy is better at less than 50Gy.Overdosage may lead to severe toxicities.

Postoperative radiotherapy for stage Ⅱ/Ⅲ rectal cancer